GeraClinic / Data / US Medicare drug spending
Medicare Part D Drug Spending (United States)
Average Medicare Part D spending per dosage unit for the most-claimed prescription drugs in the United States, from the U.S. Centers for Medicare & Medicaid Services (CMS). The figure is the weighted average Medicare spend per dosage unit β not a retail or cash price, and not a per-prescription cost.
100 drugs Β· U.S. Centers for Medicare & Medicaid Services (CMS) Β· U.S. Government Works / Public Domain
Key figures
Download & cite
This dataset summary is available as machine-readable JSON β including provenance, columns, key figures and a sample of rows β for use by researchers, journalists and AI assistants.
Methodology
The headline metric is Avg_Spnd_Per_Dsg_Unt_Wghtd_2024 (weighted avg spending per dosage unit, USD), taken verbatim from the CMS Medicare Part D Spending by Drug release. Average Medicare Part D spending per dosage unit, not a retail/cash price or per-prescription cost. For information only; not medical advice.
Sample rows
A verbatim sample from the verified snapshot. Full data is in the JSON summary and on the source page.
| drug | avgSpendPerDosageUnitUSD | partDClaims2024 |
|---|---|---|
| Atorvastatin Calcium | 0.145 | 73,349,032 |
| Amlodipine Besylate | 0.085 | 50,204,110 |
| Levothyroxine Sodium | 0.169 | 43,253,940 |
| Gabapentin | 0.119 | 36,804,628 |
| Lisinopril | 0.089 | 36,247,459 |
| Losartan Potassium | 0.126 | 36,240,406 |
Provenance
- Source:
- CMS Medicare Part D Spending by Drug
- Publisher:
- U.S. Centers for Medicare & Medicaid Services (CMS)
- Coverage:
- United States β Medicare Part D
- As of:
- data year 2024
Source: U.S. Centers for Medicare & Medicaid Services (CMS), CMS Medicare Part D Spending by Drug (release year 2026, data year 2024). U.S. Government Works / Public Domain. Re-published by GeraClinic at https://geraclinic.com/data/us-medicare-drug-prices.